Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	847163-28-4
Formula :	C₁₅H₁₁N₃O
M.W :	249.27
SMILES Code :	N#CC1=C(NC)OC(C2=C3C=CC=CC3=CC=C2)=N1
Synonyms :	CID 664510
MDL No. :	MFCD04183120
InChI Key :	DYXYXTDIFMDJIR-UHFFFAOYSA-N
Pubchem ID :	664510

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H301
Precautionary Statements:	P264-P270-P301+P310+P330-P405-P501
Class:	6.1
UN#:	2811
Packing Group:	Ⅲ

mouse islets	10 μmol/L	24 hours	ML351 reduced 12-HETE release and improved glucose-stimulated insulin secretion.	Diabetes. 2017 Nov;66(11):2875-2887
Keratinocytes in human skin equivalents	10 µM	24 or 48 hours	ML351 significantly elevated the secretion of CCL2, CCL5, and CXCL10, indicating its enhancement of keratinocyte inflammatory responses.	Cell Death Dis. 2025 Jan 22;16(1):39
NHEK/SVTERT3-5 cells	10 µM	24 hours	ML351 significantly reduced many metabolites of arachidonic and linoleic acid, indicating its inhibition of lipoxygenase activity.	Cell Death Dis. 2025 Jan 22;16(1):39
Primary spinal microglia	100 ng/ml	8 and 24 hours	To assess the effect of KLA treatment on 15-LOX-1 protein expression. KLA treatment significantly upregulated 15-LOX-1 protein expression in microglia.	Pain. 2018 Dec;159(12):2620-2629
HEK-293T cells	0.1 nM-10 μM	30 minutes	To evaluate the inhibitory effects of ML351 and ML127 on 15-LOX-1 and 12-LOX-p activity. ML351 significantly inhibited the activity of 15-LOX-1 and 12-LOX-p at low nanomolar concentrations, while ML127 preferentially reduced 15-LOX-1 activity.	Pain. 2018 Dec;159(12):2620-2629
human lung macrophages	10 μM	24 hours	To evaluate the inhibitory effect of ML351 on chemokine release induced by LPS and Th2 cytokines. Results showed that ML351 significantly inhibited LPS-induced release of CCL2 and CCL3, as well as IL-4-induced release of CCL13 and CCL22.	Br J Pharmacol. 2015 Sep;172(17):4319-30

{[proInfo.proName]}

CAS No.: 847163-28-4

{[proInfo.proName]}

CAS No.: 847163-28-4

Alternative Products

Product Details of ML351

Safety of ML351

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

C57BL/6J mice	Streptozotocin (STZ)-induced type 1 diabetes model	Intraperitoneal injection	10, 24, 48 mg/kg	Once daily, starting 5 days before STZ and ending 5 days after the last STZ dose	ML351 (10 and 24 mg/kg) prevented diabetes development, reduced β-cell oxidative stress, and preserved β-cell mass. The 48 mg/kg dose was ineffective.	Diabetes. 2017 Nov;66(11):2875-2887
Mice	Subarachnoid hemorrhage model	Intraperitoneal injection	50 mg/kg	Administered 5 minutes after SAH induction, assessed 1 and 3 days later	To evaluate the impact of ML351 on brain injury after SAH. Results showed that ML351 reduced neuronal cell death and improved neurological outcomes.	Stroke. 2019 Feb;50(2):520-523
C57BL6J mice	Transient middle cerebral artery occlusion (MCAO) model	Intraperitoneal injection	50 mg/kg	Single dose	ML351 reduced hemorrhagic transformation (HT) in wild-type mice and similarly reduced HT following tPA treatment	Stroke. 2017 Feb;48(2):445-451
Male Holtzman Sprague-Dawley rats	TLR4-dependent NSAID-unresponsive hyperalgesia model	Intrathecal injection	0.1–10 μg/10 μl	Single injection, 30 minutes pretreatment	To evaluate the inhibitory effects of ML351 and ML127 on TLR4-mediated hyperalgesia. ML351 significantly attenuated hyperalgesia at all tested doses, while ML127 showed dose-dependent inhibition at high doses.	Pain. 2018 Dec;159(12):2620-2629
Mice	LepRdb/db mice (type 2 diabetes model)	Intraperitoneal injection	100mg/kg	7 consecutive days	To evaluate the effect of ML351 on vascular function and diastolic function in diabetic mice, results showed that ML351 improved endothelium-dependent vasodilation and left ventricular diastolic function	Life Sci. 2021 Nov 1;284:119925
Male Swiss Albino mice	Ischemia/recanalization (I/R) model	Intraperitoneal injection	50 mg/kg	Single dose at recanalization	To investigate the effects of ML351 on ischemia/recanalization-induced neuroinflammation. Results showed that ML351 significantly reduced infarct volume, neurological deficit score, and lipid peroxidation, and suppressed inflammasome (NLRP1 and NLRP3) activation.	Front Cell Neurosci. 2023 Sep 26;17:1277268
Mice	Alox12 knockout mice	Intraperitoneal injection	10 mg/kg body weight	5 days prior to STZ treatment, during treatment, and 5 days post-STZ treatment, daily administration	To evaluate the protective effect of ML351 on STZ-induced glucose intolerance, results showed that ML351 treatment significantly improved glucose tolerance in Alox12 knockout mice	J Biol Chem. 2019 Apr 19;294(16):6612-6620

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed